These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 27028038)

  • 21. Nodal stage migration and prognosis in anal cancer: a systematic review, meta-regression, and simulation study.
    Sekhar H; Zwahlen M; Trelle S; Malcomson L; Kochhar R; Saunders MP; Sperrin M; van Herk M; Sebag-Montefiore D; Egger M; Renehan AG
    Lancet Oncol; 2017 Oct; 18(10):1348-1359. PubMed ID: 28802802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. French multicentre clinical evaluation of helical TomoTherapy for anal cancer in a cohort of 64 consecutive patients.
    Vendrely V; Henriques de Figueiredo B; Rio E; Benech J; Belhomme S; Lisbona A; Frison E; Doussau A; Nomikossoff N; Mahé MA; Kantor G; Maire JP
    Radiat Oncol; 2015 Aug; 10():170. PubMed ID: 26268888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term oncologic and complication outcomes in anal cancer patients treated with radiation therapy.
    Joo JH; Park JH; Yoon SM; Kim JC; Yu CS; Kim TW; Kim JH
    J Cancer Res Ther; 2020 Dec; 16(Supplement):S194-S200. PubMed ID: 33380677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prognostic significance of pretreatment leukocytosis in patients with anal cancer treated with radical chemoradiotherapy or radiotherapy.
    Banerjee R; Roxin G; Eliasziw M; Joseph K; Maclean A; Buie WD; Doll C
    Dis Colon Rectum; 2013 Sep; 56(9):1036-42. PubMed ID: 23929012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumour- and treatment-related colostomy rates following mitomycin C or cisplatin chemoradiation with or without maintenance chemotherapy in squamous cell carcinoma of the anus in the ACT II trial.
    Glynne-Jones R; Kadalayil L; Meadows HM; Cunningham D; Samuel L; Geh JI; Lowdell C; James R; Beare S; Begum R; Ledermann JA; Sebag-Montefiore D;
    Ann Oncol; 2014 Aug; 25(8):1616-22. PubMed ID: 24827136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic factors for recurrence and survival in anal cancer: generating hypotheses from the mature outcomes of the first United Kingdom Coordinating Committee on Cancer Research Anal Cancer Trial (ACT I).
    Glynne-Jones R; Sebag-Montefiore D; Adams R; Gollins S; Harrison M; Meadows HM; Jitlal M;
    Cancer; 2013 Feb; 119(4):748-55. PubMed ID: 23011911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrent squamous cell carcinoma of the anal canal. Predictors of initial treatment failure and results of salvage therapy.
    Longo WE; Vernava AM; Wade TP; Coplin MA; Virgo KS; Johnson FE
    Ann Surg; 1994 Jul; 220(1):40-9. PubMed ID: 8024357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haematotoxicity in IMRT/VMAT curatively treated anal cancer.
    Lohynská R; Nýdlová A; Drbohlavová T; Mazaná E; Jirkovská M; Veselský T; Malinová B; Stankušová H
    Klin Onkol; 2020; 33(4):288-294. PubMed ID: 32894958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intensity modulated radiotherapy in anal canal squamous cell carcinoma: Implementation and outcomes.
    Das A; Arunsingh M; Bhattacharyya T; Prasath SS; Balakrishnan A; Mallick I
    J Cancer Res Ther; 2021; 17(4):975-981. PubMed ID: 34528551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Twenty-five-year experience with radical chemoradiation for anal cancer.
    Tomaszewski JM; Link E; Leong T; Heriot A; Vazquez M; Chander S; Chu J; Foo M; Lee MT; Lynch CA; Mackay J; Michael M; Tran P; Ngan SY
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):552-8. PubMed ID: 22019078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salvage abdominoperineal resection for anal cancer following chemoradiation: a proposed scoring system for predicting postoperative survival.
    Correa JH; Castro LS; Kesley R; Dias JA; Jesus JP; Olivatto LO; Martins IO; Lopasso FP
    J Surg Oncol; 2013 Apr; 107(5):486-92. PubMed ID: 23129564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prognostic role of hemoglobin levels in patients undergoing concurrent chemo-radiation for anal cancer.
    Franco P; Montagnani F; Arcadipane F; Casadei C; Andrikou K; Martini S; Iorio GC; Scartozzi M; Mistrangelo M; Fornaro L; Cassoni P; Cascinu S; Ricardi U; Casadei Gardini A
    Radiat Oncol; 2018 May; 13(1):83. PubMed ID: 29720197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. External validation of leukocytosis and neutrophilia as a prognostic marker in anal carcinoma treated with definitive chemoradiation.
    Schernberg A; Huguet F; Moureau-Zabotto L; Chargari C; Rivin Del Campo E; Schlienger M; Escande A; Touboul E; Deutsch E
    Radiother Oncol; 2017 Jul; 124(1):110-117. PubMed ID: 28662871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy.
    Chen CC; Wang L; Lin JC; Jan JS
    J Formos Med Assoc; 2015 Mar; 114(3):231-7. PubMed ID: 25777974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of brachytherapy in the boost management of anal carcinoma with node involvement (CORS-03 study).
    Moureau-Zabotto L; Ortholan C; Hannoun-Levi JM; Teissier E; Cowen D; Salem N; Lemanski C; Ellis S; Resbeut M
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):e135-42. PubMed ID: 23195780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of human papillomavirus in anal squamous cell carcinoma.
    Ravenda PS; Magni E; Botteri E; Manzotti M; Barberis M; Vacirca D; Trovato CM; Dell'Acqua V; Leonardi MC; Sideri M; Fazio N; Zampino MG
    Cancer Chemother Pharmacol; 2014 Nov; 74(5):1033-8. PubMed ID: 25209946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of weight gain during definitive chemoradiotherapy for locally advanced non-small-cell lung cancer.
    Sher DJ; Gielda BT; Liptay MJ; Warren WH; Batus M; Fidler MJ; Garg S; Bonomi P
    Clin Lung Cancer; 2013 Jul; 14(4):370-5. PubMed ID: 23260389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High IDO1 Expression Is Associated with Poor Outcome in Patients with Anal Cancer Treated with Definitive Chemoradiotherapy.
    Mitra D; Horick NK; Brackett DG; Mouw KW; Hornick JL; Ferrone S; Hong TS; Mamon H; Clark JW; Parikh AR; Allen JN; Ryan DP; Ting DT; Deshpande V; Wo JY
    Oncologist; 2019 Jun; 24(6):e275-e283. PubMed ID: 30755500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human papillomavirus DNA load and p16INK4a expression predict for local control in patients with anal squamous cell carcinoma treated with chemoradiotherapy.
    Rödel F; Wieland U; Fraunholz I; Kitz J; Rave-Fränk M; Wolff HA; Weiss C; Wirtz R; Balermpas P; Fokas E; Rödel C
    Int J Cancer; 2015 Jan; 136(2):278-88. PubMed ID: 24839133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison between radical esophagectomy and definitive chemoradiotherapy in patients with clinical T1bN0M0 esophageal cancer.
    Motoori M; Yano M; Ishihara R; Yamamoto S; Kawaguchi Y; Tanaka K; Kishi K; Miyashiro I; Fujiwara Y; Shingai T; Noura S; Ohue M; Ohigashi H; Nakamura S; Ishikawa O
    Ann Surg Oncol; 2012 Jul; 19(7):2135-41. PubMed ID: 22302264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.